Showing results (151-160 of 264) with videos related to
Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
A Cyclin D1-Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell LymphomaSantiago Demajo, Robert Albero, Guillem Clot, et al.Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
RHOA controls oncogenic B cell receptor signaling in aggressive lymphomaAriana N Jacobs, Dominique Jahn, Tim Beringer, et al.Genes, Chromosomes & Cancer|September 8, 2007
Frequent occurrence of deletions in primary mediastinal B-cell lymphomaLindsey R Kimm, Ronald J deLeeuw, Kerry J Savage, et al.Nature|August 14, 2012
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomicsRoland Schmitz, Ryan M Young, Michele Ceribelli, et al.Cancer Cell|April 15, 2020
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic ImplicationsGeorge W Wright, Da Wei Huang, James D Phelan, et al.Blood|July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survivalDerville O'Shea, Ciarán O'Riain, Claire Taylor, et al.Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphomaMichael Chiorazzi, Lixin Rui, Yandan Yang, et al.Blood|October 1, 2011
MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotypeEllen Leich, Alberto Zamo, Heike Horn, et al.Blood|June 8, 2010
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphomaMichael A Milhollen, Tary Traore, Jennifer Adams-Duffy, et al.Science Immunology|June 7, 2020
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19Mark Roschewski, Michail S Lionakis, Jeff P Sharman, et al.Pageof 27